Corbus Pharmaceuticals Correlations
CRBP Stock | USD 17.47 0.74 4.42% |
The current 90-days correlation between Corbus Pharmaceuticals and ATyr Pharma is 0.01 (i.e., Significant diversification). The correlation of Corbus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Corbus Pharmaceuticals Correlation With Market
Average diversification
The correlation between Corbus Pharmaceuticals Holding and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Corbus Pharmaceuticals Holding and DJI in the same portfolio, assuming nothing else is changed.
Corbus |
Moving together with Corbus Stock
0.83 | VALN | Valneva SE ADR | PairCorr |
0.61 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.71 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.64 | IPSC | Century Therapeutics | PairCorr |
0.62 | MTEM | Molecular Templates | PairCorr |
0.83 | NKTX | Nkarta Inc | PairCorr |
0.61 | TPST | Tempest Therapeutics | PairCorr |
0.66 | AGL | agilon health | PairCorr |
0.85 | BACK | IMAC Holdings | PairCorr |
0.73 | CYRX | Cryoport | PairCorr |
0.68 | VFSWW | VinFast Auto | PairCorr |
0.76 | EC | Ecopetrol SA ADR | PairCorr |
Moving against Corbus Stock
0.7 | KZR | Kezar Life Sciences | PairCorr |
0.59 | MLYS | Mineralys Therapeutics, | PairCorr |
0.9 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.88 | HD | Home Depot | PairCorr |
0.84 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.81 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
0.77 | T | ATT Inc Aggressive Push | PairCorr |
0.75 | HPQ | HP Inc | PairCorr |
0.65 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.63 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.61 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
0.59 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
0.58 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
0.55 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
0.43 | KB | KB Financial Group | PairCorr |
0.42 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Corbus Stock performing well and Corbus Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Corbus Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
LIFE | 2.57 | 0.46 | 0.09 | (0.82) | 2.62 | 6.45 | 28.98 | |||
TRVI | 3.18 | (0.08) | 0.01 | 0.08 | 3.64 | 7.37 | 17.04 | |||
CUE | 7.51 | 0.80 | 0.12 | 1.05 | 5.93 | 20.27 | 67.78 | |||
ANTX | 1.90 | 0.25 | 0.08 | 0.47 | 1.86 | 3.64 | 28.03 | |||
BCAB | 4.31 | (0.24) | 0.00 | (0.03) | 0.00 | 12.86 | 31.41 | |||
KOD | 3.33 | 1.08 | 0.34 | 0.58 | 2.79 | 9.70 | 18.79 | |||
GLMD | 12.18 | 2.45 | 0.20 | (4.38) | 10.08 | 21.71 | 344.49 | |||
AFMD | 2.46 | (0.78) | 0.00 | (0.51) | 0.00 | 6.39 | 21.26 | |||
MREO | 2.65 | (0.43) | 0.00 | (0.15) | 0.00 | 5.14 | 19.32 | |||
ADVM | 2.66 | (0.40) | 0.00 | (0.10) | 0.00 | 5.04 | 16.06 |
Corbus Pharmaceuticals Corporate Management
MD MA | Chief Officer | Profile | |
Christina Bertsch | Head Resources | Profile | |
CPA MBA | Chief Officer | Profile | |
Rachael Brake | Chief Officer | Profile | |
Lindsey Smith | Head Advocacy | Profile |